BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10462554)

  • 1. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
    Sarau HM; Ames RS; Chambers J; Ellis C; Elshourbagy N; Foley JJ; Schmidt DB; Muccitelli RM; Jenkins O; Murdock PR; Herrity NC; Halsey W; Sathe G; Muir AI; Nuthulaganti P; Dytko GM; Buckley PT; Wilson S; Bergsma DJ; Hay DW
    Mol Pharmacol; 1999 Sep; 56(3):657-63. PubMed ID: 10462554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
    Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human cysteinyl leukotriene 2 receptor.
    Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
    J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
    Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
    Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
    Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
    J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
    Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
    Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
    Maekawa A; Kanaoka Y; Lam BK; Austen KF
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
    Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
    Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
    Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
    Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
    J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor.
    Woszczek G; Chen LY; Nagineni S; Kern S; Barb J; Munson PJ; Logun C; Danner RL; Shelhamer JH
    J Allergy Clin Immunol; 2008 Jan; 121(1):215-221.e1. PubMed ID: 18028998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional study on CysLT(1) receptors in human eosinophils.
    Ohshima N; Nagase H; Koshino T; Miyamasu M; Yamaguchi M; Hirai K; Yamamoto K; Fujisawa T; Nakagawa N; Kishikawa K; Morita Y
    Int Arch Allergy Immunol; 2002 Sep; 129(1):67-75. PubMed ID: 12373000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.
    Huang XQ; Zhang XY; Wang XR; Yu SY; Fang SH; Lu YB; Zhang WP; Wei EQ
    J Neuroinflammation; 2012 Jun; 9():145. PubMed ID: 22734808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
    Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional aspects of human cysteinyl leukotriene receptors.
    Capra V
    Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
    Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
    Bouchelouche K; Andersen L; Nordling J; Horn T; Bouchelouche P
    J Urol; 2003 Aug; 170(2 Pt 1):638-44. PubMed ID: 12853847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.